Sarkar Gargi, Prem Anand K, Jayasri M A, Suthindhiran K
Marine Biotechnology and Bioproducts Laboratory, Department of Biomedical Sciences, School of Biosciences and Technology, Vellore Institute of Technology, Vellore 632014, Tamil Nadu, India.
Marine Biotechnology and Bioproducts Laboratory, Department of Biomedical Sciences, School of Biosciences and Technology, Vellore Institute of Technology, Vellore 632014, Tamil Nadu, India.
J Genet Eng Biotechnol. 2025 Mar;23(1):100459. doi: 10.1016/j.jgeb.2025.100459. Epub 2025 Jan 18.
Marine halotolerant actinobacteria are robust microbes poorly explored and barely cultivable in nature. They are a trove of various secondary metabolites and enzymes, especially the alkaline proteases withstanding higher temperatures, pH, and salinity, making them an ideal source with versatile commercial and therapeutic values. This study focuses on extracting and optimizing alkaline protease production from Streptomyces sp. VITGS3 isolated from Puthuvypeen, Kerala. The protease production was optimized by Response Surface Methodology (RSM) using the Box-Behnken model, which used rice bran, wheat bran, skim milk, and casein as substrates. The maximum protease was produced (357 U/mL) using wheat bran (5.5 % w/v) as substrate at pH 9 and incubated at 45 °C for 9 days. The Michaelis-Menten model's enzyme kinetics exhibited a K value of 1.42 µM, a V of 201.64 µM·min, V of 5.59 µM·min, and K 70013.89 min suggesting a higher affinity of the enzyme for the substrate (1 % w/v casein). In addition, the protease was inhibited by the phenylmethylsulphonyl fluoride (PMSF), suggesting it belongs to the serine protease family. Finally, the application studies as contact lens cleaners showcased that the isolated protease effectively degraded the protein deposits present in the artificial tear solution without affecting the light transmittance. This is a milestone in the implication of protease on therapeutic applications and further studies on protein specificity, sustained releases, and combination strategies, resulting in crucial challenges in long-term studies, cross-reactivity, storage, and cost-effectiveness.
海洋耐盐放线菌是一类强大的微生物,在自然界中未得到充分探索且难以培养。它们是各种次生代谢产物和酶的宝库,尤其是能够耐受较高温度、pH值和盐度的碱性蛋白酶,这使其成为具有多种商业和治疗价值的理想来源。本研究聚焦于从喀拉拉邦普图维彭分离出的链霉菌属VITGS3中提取并优化碱性蛋白酶的生产。使用Box-Behnken模型通过响应面法(RSM)对蛋白酶生产进行优化,该模型以米糠、麦麸、脱脂牛奶和酪蛋白作为底物。以麦麸(5.5% w/v)为底物,在pH 9、45℃下培养9天时,产生的蛋白酶量最高(357 U/mL)。米氏模型的酶动力学显示,K值为1.42 μM,V为201.64 μM·min,V为5.59 μM·min,K为70013.89 min,表明该酶对底物(1% w/v酪蛋白)具有较高的亲和力。此外,该蛋白酶受到苯甲基磺酰氟(PMSF)的抑制,表明它属于丝氨酸蛋白酶家族。最后,作为隐形眼镜清洁剂的应用研究表明,分离出的蛋白酶能有效降解人工泪液中的蛋白质沉积物,且不影响透光率。这在蛋白酶用于治疗应用以及蛋白质特异性、缓释和联合策略的进一步研究方面是一个里程碑,在长期研究、交叉反应性、储存和成本效益方面带来了关键挑战。